Uniform Controlled Substances Act; revise Schedule I.

S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~ G1/2
26/SS26/R446
PAGE 1 (ens\kr)

To: Drug Policy
MISSISSIPPI LEGISLATURE REGULAR SESSION 2026

By: Senator(s) Turner-Ford

SENATE BILL NO. 2117

AN ACT TO AMEND SECTION 41-29-113, MISSISSIPPI CODE OF 1972, 1
TO INCLUDE 13 SUBSTANCES AS SCHEDULE I CONTROLLED SUBSTANCES 2
BECAUSE THESE DRUGS HAVE NO LEGITIMATE MEDICAL USE AND HAVE A HIGH 3
POTENCY WITH GREAT POTENTIAL TO CAUSE HARM; AND FOR RELATED 4
PURPOSES. 5
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI: 6
SECTION 1. Section 41-29-113, Mississippi Code of 1972, is 7
amended as follows: 8
41-29-113. 9
SCHEDULE I 10
(a) Schedule I consists of the drugs and other substances, 11
by whatever official name, common or usual name, chemical name, or 12
brand name designated, that is listed in this section. 13
(b) Opiates. Unless specifically excepted or unless listed 14
in another schedule, any of the following opiates, including their 15
isomers, esters, ethers, salts and salts of isomers, esters and 16
ethers, whenever the existence of these isomers, esters, ethers 17
and salts is possible within the specific chemical designation: 18
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 2 (ens\kr)

(1) Acetyl-alpha-methylfentanyl 19
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide); 20
(2) Acetylmethadol; 21
(3) Acetyl fentanyl 22
(N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); 23
(4) Acryl fentanyl 24
(N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide), also known as 25
acryloylfentanyl; 26
(5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino) 27
cyclohexylmethyl]benzamide); 28
(6) Allylprodine; 29
(7) Alphacetylmethadol, except levo-alphacetylmethadol 30
(levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM); 31
(8) Alphameprodine; 32
(9) Alphamethadol; 33
(10) Alpha′-methyl butyryl fentanyl 34
(2-methyl-N-1-phenethylpiperidin-4-yl)-N-phenylbutanamide); 35
(11) Alpha-Methylfentanyl 36
(N-[1-alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 37
1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine); 38
(12) Alpha-Methylthiofentanyl 39
(N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide40
); 41
(13) Benzethidine; 42
(14) Betacetylmethadol; 43
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 3 (ens\kr)

(15) Beta-Hydroxyfentanyl 44
(N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide); 45
(16) Beta-Hydroxy-3-methylfentanyl 46
(N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpr47
opanamide); 48
(17) Beta-Hydroxythiofentanyl 49
(N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpr50
opionamide); 51
(18) Betameprodine; 52
(19) Betamethadol; 53
(20) Beta-Methyl fentanyl 54
(N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide), also 55
known as β-methyl fentanyl; 56
(21) Beta-methylacetyl fentanyl 57
(N-phenyl-N-1-2-phenylpropyl)piperidin-4-yl)acetamide); 58
( * * *22) Beta'-Phenyl fentanyl 59
(N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide), also 60
known as β'-phenyl fentanyl or 3-phenylpropanoyl fentanyl; 61
( * * *23) Betaprodine; 62
( * * *24) Brorphine (1–(1–(1–63
(4-bromophenyl)ethyl)piperidin-4–yl)–64
1,3-dihydro-2H-benzo[d]imidazol-2-one); 65
(25) Butonitazene 66
(2-2-4-butoxybenzyl)-5-nitro-1H-benzimidazol1-yl)-N,N-diethylethan67
-1-amine); 68
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 4 (ens\kr)

( * * *26) Butyrl fentanyl 69
(N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide); 70
( * * *27) Clonitazene; 71
( * * *28) Crotonyl fentanyl 72
((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide); 73
( * * *29) Cyclopentyl fentanyl 74
(N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide); 75
( * * *30) Cyclopropyl fentanyl 76
(N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide); 77
( * * *31) Dextromoramide; 78
( * * *32) Diampromide; 79
( * * *33) Diethylthiambutene; 80
( * * *34) Difenoxin; 81
( * * *35) Dimenoxadol; 82
( * * *36) Dimepheptanol; 83
( * * *37) 2′,5′-dimethoxyfentanyl 84
(N-1-2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide); 85
( * * *38) Dimethylthiambutene; 86
( * * *39) Dioxaphetyl butyrate; 87
( * * *40) Dipipanone; 88
( * * *41) Ethylmethylthiambutene; 89
( * * *42) Etodesnitazene 90
(2-2-4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amin91
e, also known as etazene; 92
( * * *43) Etonitazene; 93
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 5 (ens\kr)

( * * *44) Etoxeridine; 94
( * * *45) Fentanyl carbamate 95
(ethyl(1-phenethylpiperidin-4-yl)(phenyl)carbamate); 96
( * * *46) Fentanyl-related substances, meaning any 97
substance not otherwise listed under another schedule and for 98
which no exemption or approval is in effect under Section 505 of 99
the Federal Food, Drug, and Cosmetic Act [21 USC 355] that is 100
structurally related to fentanyl by one or more of the following 101
modifications: 102
(A) Replacement of the phenyl portion of the 103
phenethyl group by any monocycle, whether or not further 104
substituted in or on the monocycle; 105
(B) Substitution in or on the phenethyl group with 106
alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro 107
groups; 108
(C) Substitution in or on the piperidine ring with 109
alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, 110
amino or nitro groups; 111
(D) Replacement of the aniline ring with any 112
aromatic monocycle whether or not further substituted in or on the 113
aromatic monocycle; and/or 114
(E) Replacement of the N-propionyl group by 115
another acyl group. 116
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 6 (ens\kr)

(47) Flunitazene 117
(N,N-diethyl-2-2-4-fluorobenzyl)-5-nitro-1H-benzimidazol1-yl)ethan118
-1-amine); 119
( * * *48) 4-Fluoroisobutyryl fentanyl 120
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide), 121
also known as para-fluoroisobutyryl fentanyl); 122
( * * *49) 2'-Fluoro ortho-fluorofentanyl 123
(N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl) 124
propionamide), also known as 2'-fluoro 2-fluorofentanyl; 125
( * * *50) Furanyl fentanyl 126
(N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide); 127
( * * *51) 3-furanyl fentanyl 128
(N-1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide); 129
( * * *52) Furethidine; 130
( * * *53) Hydroxypethidine; 131
( * * *54) Isobutyryl fentanyl 132
(N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide); 133
( * * *55) Isotonitazene (N,N-diethyl-2-(2-(4 134
isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine); 135
( * * *56) Isovaleryl fentanyl 136
(3-methyl-N-1-phenethylpiperidin-4-yl)-N-phenylbutanamide); 137
( * * *57) Ketobemidone (including the optical and 138
geometric isomers); 139
( * * *58) Levomoramide; 140
( * * *59) Levophenacylmorphan; 141
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 7 (ens\kr)

( * * *60) Meta-fluorofentanyl 142
(N-3-fluorophenyl)-N-1-phenethylpiperidin-4-yl)propionamide); 143
(61) Meta-fluorofuranyl fentanyl 144
(N-3-fluorophenyl)-N-1-phenethylpiperidin-4-yl)furan-2-carboxamide145
); 146
( * * *62) Meta-fluoroisobutyryl fentanyl 147
(N-(3-fluorophenyl)-N-1-phenethylpiperidin-4-yl)isobutyramide); 148
( * * *63) Methoxyacetyl fentanyl 149
(2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide); 150
(64) Metodesnitazene 151
(N,N-diethyl-2-2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-am152
ine); 153
( * * *65) 4'-Methyl acetyl fentanyl 154
(N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide); 155
( * * *66) 2-methyl AP–237 156
(1-2-methyl-4-3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one; 157
( * * *67) 3-Methylfentanyl 158
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide); 159
( * * *68) 3-Methylthiofentanyl (N-[3-methyl-1- 160
(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide); 161
( * * *69) Para-methoxyfuranyl fentanyl 162
(N-(4-methoxyphenyl)-N-1-phenethylpiperidin-4-yl)furan-2-carboxami163
de); 164
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 8 (ens\kr)

( * * *70) Metonitazene 165
(N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)e166
than-1-amine (metonitazene); 167
( * * *71) Morpheridine; 168
( * * *72) MPPP 169
(1-methyl-4-phenyl-4-propionoxypiperidine); 170
( * * *73) MT-45 171
(1-cyclohexyl-4-(1,2-diphenylethyl)piperazine); 172
( * * *74) N-pyrrolidino etonitazene 173
2-4-ethoxybenzyl)-5-nitro-1-2-pyrrolidin-1-yl)ethyl)-1H-benzimidaz174
ole, also known as etonitazepyne; 175
( * * *75) Noracymethadol; 176
( * * *76) Norlevorphanol; 177
( * * *77) Normethadone; 178
( * * *78) Norpipanone; 179
( * * *79) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N- 180
(1-phenethylpiperidin-4-yl)acetamide); 181
(80) Ortho-chlorofentanyl 182
(N-2-chlorophenyl)-N-1-phenethylpiperidin-4-yl)propionamide); 183
( * * *81) Ortho-Fluoroacryl fentanyl 184
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide); 185
( * * *82) Ortho-Fluorobutyryl fentanyl 186
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide), also 187
known as 2-fluorobutyryl fentanyl; 188
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 9 (ens\kr)

( * * *83) Ortho-Fluorofentanyl 189
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide), 190
also known as 2-fluorofentanyl; 191
( * * *84) Ortho-fluorofuranyl fentanyl 192
(N-2-fluorophenyl)-N-1-phenethylpiperidin-4-yl)furan-2-carboxamide193
); 194
( * * *85) Ortho-Fluoroisobutyryl fentanyl 195
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide); 196
(86) Ortho-methylcyclopropyl fentanyl 197
(N-2-methylphenyl)-N-1-phenethylpiperidin-4-yl)cyclopropanecarboxa198
mide); 199
( * * *87) Ortho-Methyl acetylfentanyl 200
(N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide), also 201
known as 2-methyl acetylfentanyl; 202
( * * *88) Ortho-Methyl methoxyacetyl fentanyl 203
(2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl) 204
acetamide), also known as 2-methyl methoxyacetyl fentanyl; 205
(89) Para-chlorofentanyl 206
(N-4-chlorophenyl)-N-1-phenethylpiperidin-4-yl)propionamide); 207
( * * *90) Para-Chloroisobutyryl fentanyl 208
(N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide); 209
( * * *91) Para-Fluorobutyryl fentanyl 210
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide); 211
( * * *92) Para-Fluorofentanyl (N-(4-fluorophenyl) 212
-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide); 213
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 10 (ens\kr)

( * * *93) Para-Fluoro furanyl fentanyl 214
N-(4-fluorophenyl)-N- 215
(1-phenethylpiperidin-4-yl)furan-2-carboxamide); 216
(94) Para-fluoro valeryl fentanyl 217
(N-4-fluorophenyl)-N-1-phenethylpiperidin-4-yl)pentanamide); 218
( * * *95) Para-Methoxybutyryl fentanyl 219
(N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide); 220
( * * *96) Para-methylcyclopropyl fentanyl 221
(N-4-methylphenyl)-N-1-phenethylpiperidin-4-yl)cyclopropanecarboxa222
mide); 223
( * * *97) Para-Methylfentanyl 224
(N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide), 225
also known as 4-methylfentanyl); 226
( * * *98) PEPAP 227
(1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine); 228
( * * *99) Phenadoxone; 229
( * * *100) Phenampromide; 230
( * * *101) Phenomorphan; 231
( * * *102) Phenoperidine; 232
( * * *103) Phenyl fentanyl 233
(N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide), also known as 234
benzoyl fentanyl; 235
( * * *104) Piritramide; 236
( * * *105) Proheptazine; 237
( * * *106) Properidine; 238
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 11 (ens\kr)

( * * *107) Propiram; 239
( * * *108) Protonitazene 240
N,N-diethyl-2-5-nitro-2-4-propoxybenzyl)-1H-benzimidazol-1-yl)etha241
n-1-amine; 242
( * * *109) Racemoramide; 243
( * * *110) Tetrahydrofuranyl fentanyl 244
(N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2- 245
carboxamide); 246
(111) Tetrahydrothiofuranyl fentanyl 247
(N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrothiophene-2-carbo248
xamide); 249
( * * *112) Thiofentanyl 250
(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide); 251
( * * *113) Thiofuranyl fentanyl 252
(N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide), 253
also known as 2-thiofuranyl fentanyl or thiophene fentanyl; 254
( * * *114) Tilidine; 255
( * * *115) Trimeperidine; 256
( * * *116) U-47700, (3,4-dichloro-N- 257
[2-(dimethylamino)cyclohexyl]-N-methylbenzamide); 258
( * * *117) Valeryl fentanyl 259
(N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide). 260
(c) Opium derivatives. Unless specifically excepted or 261
unless listed in another schedule, any of the following opium 262
derivatives, their salts, isomers and salts of isomers, whenever 263
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 12 (ens\kr)

the existence of these salts, isomers and salts of isomers is 264
possible within the specific chemical designation: 265
(1) Acetorphine; 266
(2) Acetyldihydrocodeine; 267
(3) Benzylmorphine; 268
(4) Codeine methylbromide; 269
(5) Codeine-N-Oxide; 270
(6) Cyprenorphine; 271
(7) Desomorphine; 272
(8) Dihydromorphine; 273
(9) Drotebanol; 274
(10) Etorphine (except hydrochloride salt); 275
(11) Heroin; 276
(12) Hydromorphinol; 277
(13) Methyldesorphine; 278
(14) Methyldihydromorphine; 279
(15) Monoacetylmorphine; 280
(16) Morphine methylbromide; 281
(17) Morphine methylsulfonate; 282
(18) Morphine-N-Oxide; 283
(19) Myrophine; 284
(20) Nicocodeine; 285
(21) Nicomorphine; 286
(22) Normorphine; 287
(23) Pholcodine; 288
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 13 (ens\kr)

(24) Thebacon. 289
(d) Hallucinogenic substances. Unless specifically excepted 290
or unless listed in another schedule, any material, compound, 291
mixture or preparation which contains any quantity of the 292
following substances, their salts, isomers (whether optical, 293
positional, or geometric) and salts of isomers, whenever the 294
existence of these salts, isomers and salts of isomers is possible 295
within the specific chemical designation: 296
(1) Alpha-ethyltryptamine; 297
(2) 4-bromo-2,5-dimethoxy-amphetamine; 298
(3) 4-bromo-2,5-dimethoxyphenethylamine; 299
(4) 2,5-dimethoxyamphetamine; 300
(5) 2,5-dimethoxy-4-ethylamphetamine (DOET); 301
(6) 2,5-dimethoxy-4-(n)-propylthiophenethylamine 302
(2C-T-7); 303
(7) 4-methoxyamphetamine; 304
(8) 5-methoxy-3,4-methylenedioxy-amphetamine; 305
(9) 4-methyl-2,5-dimethoxy-amphetamine; 306
(10) 3,4-methylenedioxy amphetamine; 307
(11) 3,4-methylenedioxymethamphetamine (MDMA); 308
(12) 3,4-methylenedioxy-N-ethylamphetamine (also known 309
as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl 310
MDA, MDE, MDEA); 311
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 14 (ens\kr)

(13) N-hydroxy-3,4-methylenedioxyamphetamine (also 312
known as N-hydroxy MDA, N-OHMDA, and 313
N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine); 314
(14) 3,4,5-trimethoxy amphetamine; 315
(15) 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT); 316
(16) Alpha-methyltryptamine (also known as AMT); 317
(17) Bufotenine; 318
(18) Diethyltryptamine; 319
(19) Dimethyltryptamine; 320
(20) 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT); 321
(21) Ibogaine; 322
(22) Lysergic acid diethylamide (LSD); 323
(23) (A) Marijuana (Hemp as defined and regulated 324
under Sections 69-25-201 through 69-25-221 and Cannabidiol 325
contained in a legend drug product approved by the Federal Food 326
and Drug Administration or obtained under Section 41-29-136 are 327
exempt under Schedule I); 328
(B) Hashish; 329
(24) Mescaline; 330
(25) Parahexyl; 331
(26) Peyote; 332
(27) N-ethyl-3-piperidyl benzilate; 333
(28) N-methyl-3-piperidyl benzilate; 334
(29) Psilocybin; 335
(30) Psilocyn; 336
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 15 (ens\kr)

(31) Tetrahydrocannabinols, meaning 337
tetrahydrocannabinols contained in a plant of the genus Cannabis 338
(cannabis plant), as well as the synthetic equivalents of the 339
substances contained in the cannabis plant, or in the resinous 340
extractives of such plant, and/or synthetic substances, 341
derivatives, and their isomers with similar chemical structure and 342
pharmacological activity to those substances contained in the 343
plant such as the following: 344
(A) 1 cis or trans tetrahydrocannabinol; 345
(B) 6 cis or trans tetrahydrocannabinol; 346
(C) 3,4 cis or trans tetrahydrocannabinol. 347
(Since nomenclature of these substances is not 348
internationally standardized, compounds of these structures, 349
regardless of atomic positions, are covered.) 350
("Tetrahydrocannabinols" excludes dronabinol and nabilone.) 351
For purposes of this paragraph, tetrahydrocannabinols do not 352
include hemp or hemp products regulated under Sections 69-25-201 353
through 69-25-221. 354
However, the following products are exempted from control: 355
(i) THC-containing industrial products made 356
from cannabis stalks (e.g., paper, rope and clothing); 357
(ii) Processed cannabis plant materials used 358
for industrial purposes, such as fiber retted from cannabis stalks 359
for use in manufacturing textiles or rope; 360
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 16 (ens\kr)

(iii) Animal feed mixtures that contain 361
sterilized cannabis seeds and other ingredients (not derived from 362
the cannabis plant) in a formula designed, marketed and 363
distributed for nonhuman consumption; 364
(iv) Personal care products that contain oil 365
from sterilized cannabis seeds, such as shampoos, soaps, and body 366
lotions (if the products do not cause THC to enter the human 367
body); 368
(v) Hemp as regulated under Sections 369
69-25-201 through 69-25-221; and 370
(vi) Any product derived from the hemp plant 371
designed for human ingestion and/or consumption that is approved 372
by the United States Food and Drug Administration; 373
(32) Phencyclidine; 374
(33) Ethylamine analog of phencyclidine (PCE); 375
(34) Pyrrolidine analog of phencyclidine (PHP, PCPy); 376
(35) Thiophene analog of phencyclidine; 377
(36) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine (TCPy); 378
(37) 4-methylmethcathinone (mephedrone); 379
(38) 3,4-methylenedioxypyrovalerone (MDPV); 380
(39) 2-(2,5-dimethoxy-4-ethylphenyl)ethanamine (2C-E); 381
(40) 2-(2,5-dimethoxy-4-methylphenyl)ethanamine (2C-D); 382
(41) 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine (2C-C); 383
(42) 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine (2C-I); 384
or 2,5-dimethoxy-4-iodophenethylamine; 385
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 17 (ens\kr)

(43) 2-[4-(ethylthio)-2,5-dimethoxyphenyl]ethanamine 386
(2C-T-2); 387
(44) 388
2-[4-(isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4); 389
(45) 2-(2,5-dimethoxyphenyl)ethanamine (2C-H); 390
(46) 2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine (2C-N); 391
(47) 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine 392
(2C-P); 393
(48) 3,4-methylenedioxy-N-methylcathinone(methylone); 394
(49) 395
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine 396
(25B-NBOMe; 2C-B-NBOMe; 25B; Cimbi-36); 397
(50) 398
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine 399
(25C-NBOMe; 2C-C-NBOMe; 25C; Cimbi-82); 400
(51) 401
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine or 402
N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe; 2C-I-NBOMe; 25I; 403
Cimbi-5); 404
(52) 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1, 405
4-benzodiazepin-2-one (also known as Phenazepam); 406
(53) 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8, 407
11,12-tetraazatricyclo[8.3.0.0]trideca-2(6),4,7,10,12-pentaene 408
(also known as Etizolam); 409
(54) Salvia divinorum; 410
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 18 (ens\kr)

(55) Synthetic cannabinoids. Unless specifically 411
excepted or unless listed in another schedule, any material, 412
compound, mixture, or preparation which contains any quantity of a 413
synthetic cannabinoid found in any of the following chemical 414
groups, whether or not substituted to any extent, or any of those 415
groups which contain any synthetic cannabinoid salts, isomers, or 416
salts of isomers, whenever the existence of such salts, isomers, 417
or salts of isomers is possible within the specific chemical 418
designation, including all synthetic cannabinoid chemical 419
analogues in such groups: 420
(A) (6aR,10aR)-9-(hydroxymethyl)-6, 421
6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c] 422
chromen-1-ol (also known as HU-210 or 423
1,1-dimethylheptyl-11-hydroxy-delta8-tetrahydrocannabinol); 424
(B) Naphthoylindoles and naphthylmethylindoles, 425
being any compound structurally derived from 3-(1-naphthoyl)indole 426
or 1H-indol-3-yl-(1-naphthyl)methane, whether or not substituted 427
in the indole ring to any extent, or in the naphthyl ring to any 428
extent; 429
(C) Naphthoylpyrroles, being any compound 430
structurally derived from 3-(1-naphthoyl)pyrrole, whether or not 431
substituted in the pyrrole ring to any extent, or in the naphthyl 432
ring to any extent; 433
(D) Naphthylmethylindenes, being any compound 434
structurally derived from 1-(1-naphthylmethyl)indene, whether or 435
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 19 (ens\kr)

not substituted in the indene ring to any extent or in the 436
naphthyl ring to any extent; 437
(E) Phenylacetylindoles, being any compound 438
structurally derived from 3-phenylacetylindole, whether or not 439
substituted in the indole ring to any extent or in the phenyl ring 440
to any extent; 441
(F) Cyclohexylphenols, being any compound 442
structurally derived from 2-(3-hydroxycyclohexyl)phenol, whether 443
or not substituted in the cyclohexyl ring to any extent or in the 444
phenolic ring to any extent; 445
(G) Benzoylindoles, whether or not substituted in 446
the indole ring to any extent or in the phenyl ring to any extent; 447
(H) Adamantoylindoles, whether or not substituted 448
in the indole ring to any extent or in the adamantoyl ring system 449
to any extent; 450
(I) Tetrahydro derivatives of cannabinol and 451
3-alkyl homologues of cannabinol or of its tetrahydro derivatives, 452
except where contained in cannabis or cannabis resin; 453
(J) 3-Cyclopropylmethanone indole or 454
3-Cyclobutylmethanone indole or 3-Cyclopentylmethanone indole by 455
substitution at the nitrogen atom of the indole ring, whether or 456
not further substituted in the indole ring to any extent, whether 457
or not substituted on the cyclopropyl, cyclobutyl or cyclopentyl 458
rings to any extent; 459
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 20 (ens\kr)

(K) Quinolinyl ester indoles, being any compound 460
structurally derived from 1H-indole-3carboxylic acid-8-quinolinyl 461
ester, whether or not substituted in the indole ring to any extent 462
or the quinolone ring to any extent; 463
(L) 3-carboxamide-1H-indazoles, whether or not 464
substituted in the indazole ring to any extent and substituted to 465
any degree on the carboxamide nitrogen and 466
3-carboxamide-1H-indoles, whether or not substituted in the indole 467
ring to any extent and substituted to any degree on the 468
carboxamide nitrogen; 469
(M) Cycloalkanemethanone Indoles, whether or not 470
substituted at the nitrogen atom on the indole ring, whether or 471
not further substituted in the indole ring to any extent, whether 472
or not substituted on the cycloalkane ring to any extent; 473
(56) Naphthalen-1-yl 474
1-(5-fluoropentyl)-1H-indole-3-carboxylate, also known as NM2201 475
or CBL2201; 476
(57) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H- 477
pyrrolo[2,3-b]pyridine-3-carboxamide, also known as 478
5F-CUMYL-P7AICA or SGT-25; 479
(58) Methyl 480
2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutano481
ate, also known as 4F-MDMB-BINACA or 4F-MDMB-BUTINACA); 482
(59) 1-(4-methoxyphenyl)-N-methylpropan-2-amine, also 483
known as para-methoxymethamphetamine or PMMA; 484
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 21 (ens\kr)

(60) Ethyl 2-(1-(5-fluoropentyl) 485
-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate, also known as 486
5F-EDMB-PINACA; 487
(61) Methyl 488
2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoa489
te, also known as 5F-MDMB-PICA or 5F-MDMB-2201; 490
(62) 491
N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide, 492
also known as FUB-AKB48 or FUB-APINACA or AKB48 493
N-(4-fluorobenzyl); 494
(63) 495
(1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)496
methanone, also known as FUB-144; 497
(64) N-ethylhexedrone, also known as 498
α-ethylaminohexanophenone or 2-(ethylamino)-1-phenylhexan-1-one; 499
(65) Alpha-pyrrolidinohexanophenone, also known as 500
α-PHP or α-pyrrolidinohexanophenone or 501
1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one); 502
(66) 4-methyl-alpha-ethylaminopentiophenone, also known 503
as 4-MEAP or 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one); 504
(67) 4'-methyl-alpha-pyrrolidinohexiophenone, also 505
known as MPHP or 4'-methyl-alpha-pyrrolidinohexanophenone or 506
1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one); 507
(68) Alpha-pyrrolidinoheptaphenone (also known as PV8; 508
1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one); 509
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 22 (ens\kr)

(69) 4'-chloro-alpha-pyrrolidinovalerophenone, also 510
known as 4-chloro-α-PVP or 4'-chloro-α-pyrrolidinopentiophenone or 511
1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one); 512
(70) 513
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one, also known as 514
methoxetamine or MXE; 515
(71) Zipeprol 516
(1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylp517
ropan-2-ol); 518
(72) Eutylone 519
(1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one); and 520
(73) ADB–BUTINACA 521
N-1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carb522
oxamide. 523
(e) Depressants. Unless specifically excepted or unless 524
listed in another schedule, any material, compound, mixture, or 525
preparation which contains any quantity of the following 526
substances having a depressant effect on the central nervous 527
system, including their salts, isomers, and salts of isomers, 528
whenever the existence of such salts, isomers, and salts of 529
isomers is possible within the specific chemical designation: 530
(1) Clonazolam, 531
6-(2-chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]532
benzodiazepine; 533
(2) Flualprazolam, 534
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 23 (ens\kr)

8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4535
]benzodiazepine; 536
(3) Flubromazepam, 537
7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 538
(4) Flubromazolam, 539
8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]540
benzodiazepin; 541
(5) Gamma-hydroxybutyric acid (other names include: 542
GHB, gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic 543
acid; sodium oxybate; sodium oxybutyrate); 544
(6) Mecloqualone; 545
(7) Methaqualone. 546
(f) Stimulants. Any material, compound, mixture or 547
preparation which contains any quantity of the following central 548
nervous system stimulants including optical salts, isomers and 549
salts of isomers unless specifically excepted or unless listed in 550
another schedule: 551
(1) Aminorex; 552
(2) Amineptine 553
(7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic 554
acid); 555
(3) N-benzylpiperazine (also known as BZP and 556
1-benzylpiperazine); 557
(4) Cathinone; 558
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 24 (ens\kr)

(5) 4,4'-Dimethylaminorex, also known as 4,4'-DMAR or 559
4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 560
4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine); 561
(6) Fenethylline; 562
(7) Mesocarb 563
(N-phenyl-N' -(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3- 564
ium-5-yl)carbamimidate); 565
(8) Methcathinone; 566
(9) Methiopropamine 567
(N-methyl-1-(thiophen-2-yl)propan-2-amine)); 568
(10) 4-methylaminorex (also known as 569
2-amino-4-methyl-5-phenyl-2-oxazoline); 570
(11) N-ethylamphetamine; 571
(12) Any material, compound, mixture or preparation 572
which contains any quantity of N,N-dimethylamphetamine. (Other 573
names include: N,N,-alpha-trimethyl-benzeneethanamine and 574
N,N-alpha-trimethylphenethylamine); 575
(13) Synthetic cathinones. (A) Unless listed in 576
another schedule, any compound other than bupropion that is 577
structurally derived from 2-Amino-1-phenyl-1-propanone by 578
modification in any of the following ways: 579
(i) By substitution in the phenyl ring to any 580
extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide 581
substituents, whether or not further substituted in the phenyl 582
ring by one or more other univalent substituents; 583
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 25 (ens\kr)

(ii) By substitution at the 3-position with 584
an alkyl substituent; 585
(iii) By substitution at the nitrogen atom 586
with alkyl or dialkyl groups, or by inclusion of the nitrogen atom 587
in a cyclic structure. 588
(B) The compounds covered in this paragraph * * * 589
(13) include, but are not limited to, any material, compound, 590
mixture or preparation which contains any quantity of a synthetic 591
cathinone found in any of the following compounds, whether or not 592
substituted to any extent, or any of these compounds which contain 593
any synthetic cathinone, or salts, isomers, or salts of isomers, 594
whenever the existence of such salts, isomers or salts of isomers 595
is possible, unless specifically excepted or listed in another 596
schedule: 597
(i) 4-methyl-N-ethylcathinone ("4-MEC"); 598
(ii) 4-methyl-alpha-pyrrolidinopropiophenone 599
("4-MePPP"); 600
(iii) Alpha-pyrrolidinopentiophenone 601
("α-PVP"); 602
(iv) 1-(1,3-benzodioxol-5-yl)-2- 603
(methylamino)butan-1-one ("butylone"); 604
(v) 2-(methylamino)-1-phenylpentan-1-one 605
("pentedrone"); 606
(vi) 1-(1,3-benzodioxol-5-yl)-2- 607
(methylamino)pentan-1-one ("pentylone"); 608
S. B. No. 2117 *SS26/R446* ~ OFFICIAL ~
26/SS26/R446
PAGE 26 (ens\kr)
ST: Uniform Controlled Substances Act; revise
Schedule I.
(vii) 4-fluoro-N-methylcathinone ("4-FMC"); 609
(viii) 3-fluoro-N-methylcathinone ("3-FMC"); 610
(ix) 1-(naphthalen-2-yl)-2- (pyrrolidin-1-yl) 611
pentan-1-one ("naphyrone"); 612
(x) Alpha-pyrrolidinobutiophenone ("α-PBP"); 613
(xi) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino) 614
-pentan-1-one (N-ethylpentylone, ephylone); 615
(xii) 616
1-1,3-benzodioxol-5-yl)-2-dimethylamino)pentan-1-one (also known 617
as dipentylone or N,N-dimethylpentylone); 618
(xiii) 4–CMC, 619
1-4-chlorophenyl)-2-methylamino)propan-1-one (also known as 620
4-chloromethcathinone); 621
(14) a-PiHP 622
4-methyl-1-phenyl-2-pyrrolidin-1-yl)pentan-1-one, also known as 623
alpha-PiHP; * * * 624
(15) 3–MMC 625
2-methylamino)-1-3-methylphenyl)propan-1-one, also known as 626
3-methylmethcathinone * * *; and 627
(16) Ethyl 2-phenyl-2-piperidin-2-yl)acetate) (also 628
known as Ethylphenidate). 629
SECTION 2. This act shall take effect and be in force from 630
and after July 1, 2026. 631